Literature DB >> 23959668

Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients.

B Naumnik, K Klejna, E Koc-Żórawska, M Myśliwiec.   

Abstract

PURPOSE: Cardiovascular disease (CVD) is a major cause of death among chronic hemodialysis (HD) patients. Gender and age belong to its classical risk factors. OPG/RANK/sRANKL (Osteoprotegerin/ Receptor Activator of Nuclear Factor κB/ soluble Receptor Activator of Nuclear Factor κB Ligand) axis constitute a system connecting bone and vascular remodeling.
METHODS: We aimed to evaluate the plasma levels of OPG, sRANKL and OPG/sRANKL ratio in 21 HD patients and 16 healthy volunteers in relation to gender, age and the other clinical parameters.
RESULTS: OPG and OPG/sRANKL ratio were significantly higher in HD patients than in controls whereas sRANKL was similar in both groups. Adjusted for gender, in controls OPG were higher in women whereas sRANKL did not differ between men and women. In HD group OPG and sRANKL were higher in women whereas OPG/sRANKL ratio was similar in both genders. Female patients compared to healthy women revealed 56% higher OPG concentration and 54% higher OPG/ sRANKL ratio. Comparison of male patients and controls revealed 61% higher level of OPG and 75% higher OPG/sRANKL ratio in HD group. Interestingly, OPG and OPG/sRANKL ratio positively correlated with age only in male patients. Contrary, the association between OPG/sRANKL ratio and age was negative in HD women.
CONCLUSION: Higher OPG levels in HD women comparing to age matched HD men indicate the necessity of more careful screening towards the presence of CVD and bone-mineral disorders. The negative association between age and OPG/ sRANKL ratio in HD women warrant in-depth study for thorough understanding of this complex interrelationship.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23959668     DOI: 10.2478/ams-2013-0026

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  5 in total

1.  Determination of NF-κB and RANKL levels in peripheral blood osteoclast precursor cells in chronic kidney disease patients.

Authors:  Gülcan Güneş; Nil Doğruer Ünal; Gülçin Eskandari; Ahmet Kiykim; Özlem Bölgen Çimen; Gülhan Temel; Mehmet Burak Y Çimen
Journal:  Int Urol Nephrol       Date:  2018-04-11       Impact factor: 2.370

2.  Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis.

Authors:  Blanca T Pacheco-Soto; Rebeca Garazi Elguezabal-Rodelo; Leonardo M Porchia; Enrique Torres-Rasgado; Ricardo Pérez-Fuentes; M Elba Gonzalez-Mejia
Journal:  J Drug Assess       Date:  2021-10-06

3.  Comprehensive assessment of tissue and serum parameters of bone metabolism in a series of orthopaedic patients.

Authors:  Jan Gunsser; Regina Hermann; Andreas Roth; Amelie Lupp
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

4.  Could Bone Biomarkers Predict Bone Turnover after Kidney Transplantation?-A Proof-of-Concept Study.

Authors:  Juliana Magalhães; Janete Quelhas-Santos; Luciano Pereira; Ricardo Neto; Inês Castro-Ferreira; Sandra Martins; João Miguel Frazão; Catarina Carvalho
Journal:  J Clin Med       Date:  2022-01-17       Impact factor: 4.241

5.  The Short-Term Effect of Prunes in Improving Bone in Men.

Authors:  Kelli S George; Joseph Munoz; Lauren T Ormsbee; Neda S Akhavan; Elizabeth M Foley; Shalom C Siebert; Jeong-Su Kim; Robert C Hickner; Bahram H Arjmandi
Journal:  Nutrients       Date:  2022-01-10       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.